In the final part of his interview with The American Journal of Managed Care®, Jordan Karlitz, MD, of Exact Sciences, discussed clinical-, behavioral-, and policy-based interventions he believes could ...

BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in ...

Metabolic syndrome and its components, including obesity and hypertension, significantly increase the risk for precancerous polyp recurrence.

Montell Jordan reflected on how fellow entertainer James Van Der Beek's public cancer battle reshaped his own outlook on fighting the disease, saying both men's journeys serve different audiences whil ...

This recent readout follows successful data from another combination including Braftovi in mCRC.

Adagene Inc. ('Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel ...

US FDA clears CStone’s IND application for novel trispecific antibody CS2009 to advance into phase II trial: Suzhou, China Tuesday, February 17, 2026, 11:00 Hrs [IST] CStone Pha ...

Rhythm strikes distribution deal with 4Cyte Pathology for its ColoSTAT® bowel cancer assay. ... Read More The post Rhythm inks major local distribution deal for its ColoSTAT bowel cancer test appeared ...

Long-term low-dose aspirin use is associated with a significantly reduced risk for colorectal cancer and all-cause mortality among those with IBD.

Net proceeds from the private placement will be used to fund ongoing operations, address outstanding liabilities, and preserve the company's ability to operate.